SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-043670
Filing Date
2018-11-26
Accepted
2018-11-26 16:02:08
Documents
4
Period of Report
2018-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002554x3_8k.htm 8-K 29115
2 EXHIBIT 99.1 s002554x3_ex99-1.htm EX-99.1 22417
3 image0.jpg GRAPHIC 85253
4 image1.jpg GRAPHIC 114985
  Complete submission text file 0001140361-18-043670.txt   328666
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 181200930
SIC: 2834 Pharmaceutical Preparations